tranexamic acid has been researched along with Hematoma, Subdural in 5 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Hematoma, Subdural: Accumulation of blood in the SUBDURAL SPACE between the DURA MATER and the arachnoidal layer of the MENINGES. This condition primarily occurs over the surface of a CEREBRAL HEMISPHERE, but may develop in the spinal canal (HEMATOMA, SUBDURAL, SPINAL). Subdural hematoma can be classified as the acute or the chronic form, with immediate or delayed symptom onset, respectively. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Management of nonemergent, nonacute subdural hematomas (SDHs) ranges from observation to burr-hole evacuation or craniotomy, but recurrence rates are high." | 1.43 | Tranexamic Acid for Treatment of Residual Subdural Hematoma After Bedside Twist-Drill Evacuation. ( Bravate, C; Frisoli, FA; Harrison, G; Huang, PP; Kondziolka, D; Pacione, D; Tanweer, O, 2016) |
| " TXA was administered, in the same dosing and scheduled course, to all patients." | 1.43 | Tranexamic Acid for Recurring Subdural Hematomas Following Surgical Evacuation: A Clinical Case Series. ( Hutchins, L; Stary, JM; Vega, RA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anker-Møller, T | 1 |
| Troldborg, A | 1 |
| Sunde, N | 1 |
| Hvas, AM | 1 |
| Ebrahimi, P | 1 |
| Mozafari, J | 1 |
| Ilkhchi, RB | 1 |
| Hanafi, MG | 1 |
| Mousavinejad, M | 1 |
| Tanweer, O | 1 |
| Frisoli, FA | 1 |
| Bravate, C | 1 |
| Harrison, G | 1 |
| Pacione, D | 1 |
| Kondziolka, D | 1 |
| Huang, PP | 1 |
| Stary, JM | 1 |
| Hutchins, L | 1 |
| Vega, RA | 1 |
| Vujkovac, B | 1 |
| Sabovic, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma. A Double-blind, Placebo-controlled, Multicentre, Randomized Controlled Clinical Trial[NCT03582293] | Phase 3 | 140 participants (Anticipated) | Interventional | 2018-06-19 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tranexamic acid and Hematoma, Subdural
| Article | Year |
|---|---|
Evidence for the Use of Tranexamic Acid in Subarachnoid and Subdural Hemorrhage: A Systematic Review.
Topics: Antifibrinolytic Agents; Hematoma, Subdural; Humans; Recurrence; Subarachnoid Hemorrhage; Survival R | 2017 |
1 trial available for tranexamic acid and Hematoma, Subdural
| Article | Year |
|---|---|
Intravenous Tranexamic Acid for Subdural and Epidural Intracranial Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Antifibrinolytic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follo | 2019 |
3 other studies available for tranexamic acid and Hematoma, Subdural
| Article | Year |
|---|---|
Tranexamic Acid for Treatment of Residual Subdural Hematoma After Bedside Twist-Drill Evacuation.
Topics: Adult; Aged; Antifibrinolytic Agents; Combined Modality Therapy; Craniotomy; Drainage; Female; Hemat | 2016 |
Tranexamic Acid for Recurring Subdural Hematomas Following Surgical Evacuation: A Clinical Case Series.
Topics: Adult; Aged, 80 and over; Antifibrinolytic Agents; Brain; Craniotomy; Female; Hematoma, Subdural; Hu | 2016 |
Treatment of subdural and intracerebral haematomas in a haemodialysis patient with tranexamic acid.
Topics: Aged; Antifibrinolytic Agents; Hematoma; Hematoma, Subdural; Humans; Intracranial Hemorrhages; Male; | 2000 |